Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice by unknown
Impellizzeri et al. Arthritis Research & Therapy  (2016) 18:101 
DOI 10.1186/s13075-016-0999-9ERRATUM Open AccessErratum to: Palmitoylethanolamide and
luteolin ameliorate development of arthritis
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Daniela Impellizzeri1†, Emanuela Esposito1†, Rosanna Di Paola1, Akbar Ahmad1, Michela Campolo1, Angelo Peli2,
Valeria Maria Morittu3, Domenico Britti3 and Salvatore Cuzzocrea1,4*The authors would like to issue an erratum for this article
[1], and would like to declare the following competing
interests which we inadvertently failed to include in our
original publication. The authors would like to apologise
for this omission.
In addition, a detailed method for co-ultramicronization
process is reported:
Co-ultramicronization process was performed in a
jet-mill equipment endowed with a chamber of 300 mm
in diameter which operates with “spiral technology” and
was driven by compressed air at 10-12 bars. The crashing
is determined by the high number of collisions that occurs
among particles, as a result of the high level of kinetic –
not mechanical - energy. This process was effective not
only in reducing the products particle size, but also in
modifying their crystalline structure. Observations by
scanning electron microscopy (SEM) shows an intimate
intermixing of the two components of the composite,
while analysis throw differential scanning calorimetry
(DSC) and X-ray diffraction (XRD) have documented
the transformation in a new crystalline form different
from the original two, definable with “a higher energy
content form.” The composite shows the following
particle size distribution: 96 % <10 μm; 80 % <5 μm;
40 % <2 μm (J Neuroinflammation 2013 10:91).* Correspondence: salvator@unime.it
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